Cancer Research UK Cambridge Institute
-
In Memoriam: Professor Greg Hannon (1964–2026)
It is with profound sadness that we share the news of the passing of Professor Greg Hannon, who led the Cancer Research UK Cambridge Institute for over eight years.
Greg was already a world-renowned scientist when appointed Director, and for the community, he was a visionary leader, a cherished mentor, and a singular force of nature whose influence shaped the research landscape.
Beyond his international recognition, those of us who had the privilege of knowing Greg will remember him for his remarkable and unique intelligence, his good humour, and his sharp wit.
Tribute to Prof Greg Hannon
Research Themes
We are a world-leading cancer research institute dedicated to improving patient lives through discovery science.
-
Artificial intelligence
Using artificial intelligence to enhance cancer research and treatments.
Find out more -
Cancer detection
Improving early cancer diagnoses and predicting treatment response.
Find out more -
Cell biology
Understanding every stage of a tumour through discovery science.
Find out more -
Clinical integration
Maximising patient data for better cancer care.
Find out more -
Personalised medicine
Tailoring cancer treatment to individual needs.
Find out more -
Tumour microenvironment
Unravelling tumour interactions to identify potential drug targets.
Find out more
About us
We have built a truly collaborative culture, fostering connections between scientists, healthcare organisations, and industry to take our cancer research from bench to bedside.
Read moreLatest News
See all news-
Shankar Balasubramanian receives the Princess of Asturias Award for Scientific and Technical Research
14th May 2026
The 2026 award recognises Prof Balasubramanian and his co-recipients David Klenerman and Pascal Meyer for their pioneering work in genome sequencing technologies.
Find out more -
Prof Sir Steve Jackson receives the 2026 Galen Medal in Therapeutics
14th May 2026
This award comes in recognition of his transformational work on the mechanisms of DNA repair, cell survival and the DNA-damage response (DDR), as well as for the development of the cancer-targeting drug Olaparib.
Find out more -
In Memoriam: Professor Greg Hannon (1964–2026)
9th April 2026
It is with profound sadness that we share the news of the passing of Professor Greg Hannon, who led the Cancer Research UK Cambridge Institute for over eight years.
Find out more
Our Progress
Our research is already making a positive impact for patients and their families.
-
14 Spin-out companies developing new treatments and technologies
-
200 PhD students trained to become future leaders in cancer research.
-
750 We’ve been cited over 750,000 times, leading the field.
Join us
We provide a creative and supportive environment for all our staff and students to build a career that makes a real difference.
Find out more